Showing 38,141 - 38,160 results of 102,197 for search '(( i et decrease ) OR ( 5 ((nn decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.73s Refine Results
  1. 38141
  2. 38142
  3. 38143

    Standardized performance precision analysis as a function of number of projects aggregated. by Austin Chou (2558950)

    Published 2022
    “…<p>As the number of projects increased, the performance precision improved (i.e. standardized performance CI width decreased). (A, B) By LogLoss, BP<sub>log</sub> started with a standardized performance precision of 5.22 ± 0.24% with 2-project aggregation and decreased to an average of 1.85 ± 0.01% with 25-project aggregation (A). …”
  4. 38144

    Model-predicted effect of once a day administration of 1000 mg of acetazolamide. by Nicholas Heming (510208)

    Published 2014
    “…Minute ventilation is predicted to increase by more than 0.75 l min<sup>−1</sup> in 65% of patients (A) and PaCO<sub>2</sub> is predicted to decrease by 5 mmHg in 45% of patients (B) supported by pressure support ventilation treated by 1000 mg day<sup>−1</sup> of acetazolamide. …”
  5. 38145
  6. 38146

    A large proportion of NSCs redivide within 24 to 72 h. by Valerio Lupperger (9745714)

    Published 2020
    “…(B–E) Example DLS (yellow arrow) for a labeling interval Δt = 9 h. (F) The DLS proportion is high for Δt = 9 h and decreases rapidly with increasing Δt. …”
  7. 38147
  8. 38148

    Data Sheet 1_Pathologic complete response after neoadjuvant therapy for locally advanced rectal cancer in a real-world setting: a population-based study.docx by Lina Cadili (21448478)

    Published 2025
    “…Aim<p>This study aimed to determine the impact of time from neoadjuvant therapy (NAT) to surgery on the complete pathologic response (pCR) rate in patients with locally advanced rectal cancer. NAT decreases the local recurrence of rectal cancer. Some patients achieve a pCR. …”
  9. 38149

    Baseline characteristics. by Nattapat Nitinai (17896679)

    Published 2024
    “…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”
  10. 38150

    Subgroup analyses for the primary outcome. by Nattapat Nitinai (17896679)

    Published 2024
    “…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”
  11. 38151

    Outcomes. by Nattapat Nitinai (17896679)

    Published 2024
    “…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”
  12. 38152

    Trial profile. by Nattapat Nitinai (17896679)

    Published 2024
    “…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”
  13. 38153

    Utilizing reduction in spheroid counts and/or total nuclear intensity to determine toxic effects of compounds. by Pranjali Beri (14945400)

    Published 2023
    “…They are indicated appropriately in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0287809#pone.0287809.g004" target="_blank">Fig 4</a>. …”
  14. 38154

    Mutagenesis of the CXCL10 binding site on <i>L</i>. <i>(L</i>.<i>) major</i> GP63 to <i>L</i>. <i>(V</i>.<i>) panamensis</i> residues reduces CXCL10 cleavage and T cell chemotaxis. by Alejandro L. Antonia (7147739)

    Published 2021
    “…(L.) major gp63 <i>allele (D463) to the</i> L. (V.) panamensis <i>allele (N463) at the CXCL10 binding site decreases CXCR3</i><sup><i>+</i></sup> <i>T cell chemotaxis</i>. …”
  15. 38155

    Synthesis of a Dialuminum-Substituted Silicotungstate and the Diastereoselective Cyclization of Citronellal Derivatives by Yuji Kikukawa (1929586)

    Published 2008
    “…The reaction of <b>1</b> with pyridine yielded TBA<sub>3</sub>[(C<sub>5</sub>H<sub>5</sub>N)H][γ-SiW<sub>10</sub>O<sub>36</sub>{Al(C<sub>5</sub>H<sub>5</sub>N)}<sub>2</sub>(μ-OH)<sub>2</sub>]·2H<sub>2</sub>O (<b>2</b>), and the molecular structure was successfully determined by the X-ray crystallographic analysis. …”
  16. 38156

    Synthesis of a Dialuminum-Substituted Silicotungstate and the Diastereoselective Cyclization of Citronellal Derivatives by Yuji Kikukawa (1929586)

    Published 2008
    “…The reaction of <b>1</b> with pyridine yielded TBA<sub>3</sub>[(C<sub>5</sub>H<sub>5</sub>N)H][γ-SiW<sub>10</sub>O<sub>36</sub>{Al(C<sub>5</sub>H<sub>5</sub>N)}<sub>2</sub>(μ-OH)<sub>2</sub>]·2H<sub>2</sub>O (<b>2</b>), and the molecular structure was successfully determined by the X-ray crystallographic analysis. …”
  17. 38157

    Bacterial strains used in this study. by Malin-Theres Seffer (14808772)

    Published 2023
    “…<i>aureus</i> in human plasma was approximately 5 x 10<sup>8</sup> cells.</p><p>Conclusions</p><p>The Seraph affinity filter, based on heparin-coated beads, is a highly efficient method for reducing <i>S</i>. …”
  18. 38158

    Stability of FeF<sub>3</sub>‑Based Sodium-Ion Batteries in Nonflammable Ionic Liquid Electrolytes at Room and Elevated Temperatures by Zifei Sun (11576725)

    Published 2022
    “…The Pyr<sub>1,4</sub>FSI electrolyte demonstrated the best cycling stability with an unprecedented decay rate of only ∼0.023% per cycle after the initial stabilization and an average coulombic efficiency of ∼99.5% for over 1000 cycles at RT. The Pyr<sub>1,3</sub>FSI electrolyte demonstrated the best cycling stability with a capacity decay rate of only ∼0.25% per cycle at 60 °C. …”
  19. 38159

    ABCA1 plays a key role in the inhibition of HCV infection. by Simone Bocchetta (539356)

    Published 2014
    “…<p>(A) Silencing of ABCA1. Huh7.5 cells were transfected with siRNA that targets ABCA1, or with a control siRNA. …”
  20. 38160

    <i>Foxj1</i> as a target gene for RFX4. by Ping Xu (122619)

    Published 2018
    “…<p>(A) qPCR. <i>Foxj1</i> mRNA levels were decreased in E12.5 KO brains, whereas there were no significant differences in <i>Ift172</i>, <i>Thbs</i>, <i>Dync2li1</i>, <i>Rfx2</i>, <i>Rfx3</i> mRNAs, and almost undetectable <i>Rfx4</i> transcripts compared to the controls (P< 0.0001, n = 5). …”